Larry D. Hall

642 total citations
9 papers, 510 citations indexed

About

Larry D. Hall is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Larry D. Hall has authored 9 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Larry D. Hall's work include Diabetes Management and Research (4 papers), Pancreatic function and diabetes (3 papers) and Pharmacology and Obesity Treatment (2 papers). Larry D. Hall is often cited by papers focused on Diabetes Management and Research (4 papers), Pancreatic function and diabetes (3 papers) and Pharmacology and Obesity Treatment (2 papers). Larry D. Hall collaborates with scholars based in United States and Canada. Larry D. Hall's co-authors include R. Westland, John E. Gerich, Morey W. Haymond, Robert A. Rizza, F. John Service, R. A. Rizza, V. L. W. Go, Peter C. O’Brien, Stephen F. Brady and A H Clemens and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Larry D. Hall

9 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Larry D. Hall United States	6	291	156	130	102	72	9	510
J. C. Sodoyez Belgium	14	205 0.7×	146 0.9×	156 1.2×	75 0.7×	107 1.5×	21	518
M. Alberetto Italy	13	205 0.7×	127 0.8×	116 0.9×	49 0.5×	69 1.0×	26	540
E. M. Guntsche United States	7	218 0.7×	104 0.7×	110 0.8×	153 1.5×	47 0.7×	9	460
Richard Deacon Switzerland	12	72 0.2×	191 1.2×	120 0.9×	183 1.8×	26 0.4×	15	409
Dirk R. Davis United States	5	144 0.5×	41 0.3×	72 0.6×	42 0.4×	19 0.3×	6	537
K. M. MacLeod United Kingdom	11	325 1.1×	68 0.4×	106 0.8×	70 0.7×	150 2.1×	16	553
D Fonzo Italy	12	218 0.7×	54 0.3×	87 0.7×	34 0.3×	48 0.7×	34	425
Yoshiharu Yamamura Japan	10	76 0.3×	67 0.4×	59 0.5×	63 0.6×	28 0.4×	39	480
Hanne M. M. Rooijackers Netherlands	12	157 0.5×	74 0.5×	70 0.5×	65 0.6×	83 1.2×	12	382
M C Raux-Demay France	16	548 1.9×	433 2.8×	96 0.7×	23 0.2×	167 2.3×	26	806

Countries citing papers authored by Larry D. Hall

Since Specialization

Citations

This map shows the geographic impact of Larry D. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry D. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry D. Hall more than expected).

Fields of papers citing papers by Larry D. Hall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry D. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry D. Hall. The network helps show where Larry D. Hall may publish in the future.

Co-authorship network of co-authors of Larry D. Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Larry D. Hall. A scholar is included among the top collaborators of Larry D. Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry D. Hall. Larry D. Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Martin, Clyde F., et al.. (1984). Effect of a zinc phosphate suspension of a long-acting somatostatin analog on postprandial plasma glucose, triglyceride and glucagon concentrations in alloxan diabetic dogs. Life Sciences. 35(26). 2627–2633. 3 indexed citations

Veber, Daniel F., Richard Saperstein, Ruth F. Nutt, et al.. (1984). A super active cyclic hexapeptide analog of somatostatin. Life Sciences. 34(14). 1371–1378. 122 indexed citations

Service, F. John, R. A. Rizza, R. Westland, et al.. (1984). Gastric Inhibitory Polypeptide in Obesity and Diabetes Mellitus*. The Journal of Clinical Endocrinology & Metabolism. 58(6). 1133–1140. 37 indexed citations

Service, F. John, Larry D. Hall, R. Westland, et al.. (1983). Effects of size, time of day and sequence of meal ingestion on carbohydrate tolerance in normal subjects. Diabetologia. 25(4). 89 indexed citations

Service, F. John, R. A. Rizza, Larry D. Hall, et al.. (1983). Prandial Insulin Requirements in Insulin-Dependent Diabetics: Effects of Size, Time of Day, and Sequence of Meals. The Journal of Clinical Endocrinology & Metabolism. 57(5). 931–936. 23 indexed citations

Rizza, R. A., R. Westland, Larry D. Hall, et al.. (1982). Subcutaneous versus intraperitoneal administration of insulin on post-prandial hyperglycaemia and glucose turnover in alloxan diabetic dogs. Diabetologia. 23(1). 61–4. 4 indexed citations

Service, F. John, R. A. Rizza, R. Westland, et al.. (1980). Considerations for the Programming of an Open-Loop Insulin Infusion Device from the Biostator Glucose Controller. Diabetes Care. 3(2). 278–284. 17 indexed citations

Rizza, Robert A., et al.. (1980). Control of Blood Sugar in Insulin-Dependent Diabetes: Comparison of an Artificial Endocrine Pancreas, Continuous Subcutaneous Insulin Infusion, and Intensified Conventional Insulin Therapy. New England Journal of Medicine. 303(23). 1313–1318. 213 indexed citations

Hall, Larry D., et al.. (1979). Black Farm Operators and Farm Population, 1900-1970: Alabama and Kentucky. Phylon (1960-). 40(4). 387–387. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact